SOLOXINE Trademark

Trademark Overview

On Wednesday, December 4, 2024, a trademark application was filed for SOLOXINE with the United States Patent and Trademark Office. The USPTO has given the SOLOXINE trademark a serial number of 98884656. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, July 18, 2025. This trademark is owned by Virbac AH, Inc.. The SOLOXINE trademark is filed in the Pharmaceutical Products category with the following description:

Medication for the treatment of hypothyroidism in animals.
soloxine

General Information

Serial Number98884656
Word MarkSOLOXINE
Filing DateWednesday, December 4, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, July 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedication for the treatment of hypothyroidism in animals.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVirbac AH, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestlake, TX 76137

Trademark Events

Event DateEvent Description
Wednesday, December 4, 2024NEW APPLICATION ENTERED
Saturday, May 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 23, 2025ASSIGNED TO EXAMINER
Friday, May 23, 2025NON-FINAL ACTION WRITTEN
Friday, May 23, 2025NON-FINAL ACTION E-MAILED
Wednesday, July 16, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 16, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 16, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 18, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 16, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 16, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

soloxine animals hypothyroidism treatment medication